Oral Silodosin on Lower Urinary Tract Symptoms Due to Double-J stent: A Prospectively Randomized Study

Phase 4

Completed

• Conditions: urinary symptoms assosciated with indwelling double-J ureteral stents; Renal and Urogenital - Other renal and urogenital disorders

• Registration Number: ACTRN12611000569909
• Lead Sponsor: Chung Jing Wang

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-06-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

patients, with insertion of a double-J ureteral stent after ureteroscopic stone removal, were enrolled into the study

Exclusion Criteria

benign prostatic hyperplasia-related lower urinary symptoms(International Prostate Symptom Score greater greater than 7); a history of interstitial cystitis, chronic cystitis, chronic prostatitis, or stent insertion; and chronic medication with alpha-blockers or analgesics

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ureteral stent symptom questionnaire (USSQ) evaluating the symptoms associated with double-J stents[at 2nd week and 4th week];quality of life of International Prostate Symptom Scale (IPSS) evaluating the symptoms associated with double-J stents[at 2nd week and 4th week]

Secondary Outcome Measures

Name	Time	Method
il[Nil]